Archives
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-29
Use this dual-readout reporter to separate mRNA uptake from productive protein expression in nanoparticle, macrophage, and quantitative transfection studies. The Cy5 channel tracks delivery and trafficking, while EGFP reports translation, making optimization faster than relying on a single endpoint.
-
BRCA2, PARP1 Retention, and RAD51 Filament Protection
2026-08-28
The 2025 Nature study identifies PARP inhibitor–mediated PARP1 retention on resected DNA as a direct threat to RAD51 filament stability, and shows that full-length BRCA2 counteracts this effect. Its combination of biochemical reconstitution, single-molecule fluorescence, and cellular localization establishes a mechanistic link between BRCA2 status and PARP inhibitor sensitivity.
-
circHIF1A Axis Drives M2 Polarization in LUAD
2026-08-28
This study identifies a circHIF1A/miR-486-5p/GRHL2 axis that links malignant lung adenocarcinoma behavior with macrophage M2 polarization and IL-10-associated immunosuppression. Its integrated tissue, cell, and xenograft design provides a mechanistic framework for evaluating circular RNA regulation of both tumor cells and the immune microenvironment.
-
Biotin-Tyramide for TSA and Proximity Labeling
2026-08-27
Biotin-tyramide is an HRP-responsive biotinylation reagent for spatial signal amplification in fixed-cell imaging, immunohistochemistry, and in situ hybridization. Its biotin phenol-like radical chemistry supports localized deposition that can be read with streptavidin-based fluorescence or chromogenic systems.
-
1-methyl Adenosine: From RNA Mark to Biomarker
2026-08-27
Explore how 1-methyl Adenosine and 1-methyl Ado connect RNA turnover with cancer metabolism studies, biomarker discovery, and better quantitative assay design.
-
28S rRNA Expansion Segments Build Nucleolar Layers
2026-08-26
Wei and colleagues show that 28S rRNA expansion segments act as multivalent architectural elements that can reconstitute layered nucleolar-like structures. Their combination of cellular localization, in vitro assembly, comparative species analysis, targeted deletion, segment transfer, and simulation connects evolutionary RNA expansion with nucleolar complexity.
-
Bradykinin BA5201: Practical Research Guide
2026-08-26
Bradykinin (BA5201) provides a research peptide for controlled studies of endothelium-dependent vasodilation, vascular permeability, smooth muscle contraction, pain mechanisms, and inflammatory responses. It is intended for laboratory use only; the dossier does not support diagnostic, clinical, or therapeutic applications, and assay-specific concentrations and exposure conditions must be established by the researcher.
-
1-methyl Adenosine: Workflow and Assay Guide
2026-08-25
Build cleaner 1-methyl Adenosine experiments by combining controlled cell exposure, matrix-aware extraction, and isomer-resolved UHPLC–MS/MS. The workflow supports RNA modification research, cancer metabolism studies, biomarker discovery, and carefully controlled therapeutic target validation.
-
L. gasseri ATCC33323, NR1I3, and Colitis Barrier
2026-08-25
The reference study identifies an E-cadherin-centered mechanism by which Lactobacillus gasseri ATCC33323 reduces DSS-induced colitis in mice. Its combination of intestinal E-cadherin perturbation, transcriptional analysis, and in vitro validation connects probiotic treatment with NR1I3-mediated regulation of CDH1, while also highlighting the limits of translating a chemical injury model into human inflammatory bowel disease.
-
CasKAS: Genome-Wide CRISPR Specificity by ssDNA Mapping
2026-08-24
CasKAS introduces a chemical ssDNA-mapping strategy for profiling genome-wide Cas9 and dCas9 binding specificity. By detecting the unwound DNA created when an sgRNA-loaded CRISPR enzyme engages a target, the method provides a rapid and comparatively accessible complement to cleavage- and occupancy-based assays.
-
ARCA Cy3 EGFP mRNA (5-moUTP) Workflow Guide
2026-08-24
ARCA Cy3 EGFP mRNA (5-moUTP) combines direct Cy3 tracking with EGFP reporter expression, allowing researchers to separate cellular uptake from productive translation. This guide presents practical workflows for mammalian-cell delivery studies, formulation benchmarking, localization assays, and troubleshooting.
-
PLAC1 Targeting in Clear Cell Renal Cell Carcinoma
2026-08-23
A 2025 study identifies PLAC1 as both a prognostic biomarker and a candidate molecular target in clear cell renal cell carcinoma. By combining TCGA analysis, protein-level validation, PLAC1 knockdown, and high-throughput virtual screening, the authors nominate Amaronol B and canagliflozin for experimental follow-up.
-
Tetracycline Hydrochloride: Applied Workflows
2026-08-22
Build more reproducible bacterial growth, translation, and microbiome experiments with Tetracycline Hydrochloride. This guide emphasizes formulation control, bacteriostatic-versus-bactericidal readouts, and a carefully bounded comparison with rapid ROS-driven cancer assays.
-
O-propargyl-puromycin (OPP) for Translation Assays
2026-08-21
Learn how O-propargyl-puromycin (OPP), SKU A8778, separates nascent protein synthesis from viability and metabolic readouts in cell-based assays. This scenario-driven guide covers assay design, click-chemistry compatibility, optimization, interpretation, and practical reagent selection.
-
Neomycin Sulfate: Designing Mechanistic Assays
2026-08-21
Neomycin sulfate is more than an aminoglycoside antibiotic: it is a context-dependent probe for RNA, DNA, and ion-channel mechanisms. This guide shows how to convert its distinct binding and blocking behaviors into better-controlled assays, while extracting practical lessons from microbiome and immunology research.